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FIBRIN SEALING - AN ADVANCED THERAPY IN DEALING WITH PREMATURE
RUPTURE OF MEMBRANES?
Kurz, C.S. , A. Huch
In 1979 Genz reported two cases.of f ibr in sealing (FS) therapy in
premature rupture of membranes (PRM) (2). In 1980 Diaz-Zagoya et
al . reported on in vitro sealing of ruptured fetal membranes with
f ibr in cryoprecipitate (1) . The sealed membranes were able to tole-
rate hydrostatic pressures on the fetal side up to 60 mmHg without
rupture. They concluded that f ibr in seals ruptured membranes in
vitro.
P R I N C I P L E AND TECHNIQUE OF FS
The principle of FS therapy is to stem the flow of amniotic f l u i d
(AF) and by this means to facilitate the renewal of chorion and
amnion. The f ib r in in this context has to seal the lower amniotic
sac from the cervix. Direct sealing of the ruptured membranes is
not possible. The basic principle of clot formation is the poly-
merisation of the f ibr in monomer in the 2nd stage of blood clotting.
Fibrinolysis is prevented by the addition of proteinase inhibitors.
The f ib r in kit contains lyophil ized f ibr in seal, each ml of which
has 75 mg of clottable protein, aprotinin and CaC12. The stabili-
zation of this f ibr in solution is achieved by adding 500 ILl/ml
thrombin. The f ib r in seal solution is taken up in a sterile syringe
and appl ied via a canula placed in the cervix. Before and after
this procedure the same volume of thrombin-CaC12 solution is
applied to the endocervix. The position of the cervix has to remain
fixed until the FS is complete. The f inal hardening is achieved
after 2 hours.
PATIENTS AND METHODS
The study was made on 6 patients between the 19th and 30th weeks of
gestation. The use of FS was carried out for a total of 13 times;
in 5 patients the procedere was employed twice and in one other
three times. In one case a cervical suture had already performed
just before; in the other cases the cervix was intact. All patients
had been treated with fenoterol and prophylactic antibiotic therapy
was employed. The patients were put into lithotomy position, and
the vu lva , vagina and cervix washed thoroughly with an antiseptic
solution. After FS the fo l lowing daily investigations were carried
out for the exclusion of a subsequent developing anmion infection
syndrome (AIS): pulse, temperature, ESR, white cell count. The
patients were kept under strict bed rest for 10 days after appli-
cation.
RESULTS
Apart from one case, where the diagnosis of PRM was questjonable,
leakage of AF continued over the fol lowing 3 days, and furthermore
the 2nd and 3nd application of the FS failed to stem the flow.
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There existed no relationship between the rupture of membranes and
application of the FS, which varied frpm 1 to 12 days. The f ib r in
p lug would either be reabsorbed or expelled wi th in 3 days. In no
case did an AIS develop.
DISCUSSION
What can be the reasons fo.r this fai lure of FS?
1.)There is no good evidence for adherence between the f ib r in and
the endocervix (2) .
2.)The poor adherence observed may result frpm too low a f ibr in
concentration.
3.)The cervix consists of a round cylinder rather than two fl.at
surfaces.
4.)The endocervix may also be too wet to al low effective hardening
of the FS.
5.)The continuous formation of AF may exert an increasing pressure
upon the region of the f ibr in plug.
To attempt to improve the technique we modified the method taking
into account point 2 and 4. In vitro experiments were carried out
on four fresh human uteruses obtained after hysterectomy frpm pre-
menopausal women. The endocervix was swabbed äs far äs possible and
the concentration of the FS was increased to 90 mg/ml. The fresh
uteruses were placed in a warm chamber at 37 C. Fibrin-aprotinin
and thrombin were applied not successively, but simultaneously
using a double-syringe. This technique allowed a good init ial poly-
merisation and hardening. But after approximately one and a half
hour the f ibr in plug showed no adherence when s l ight traction or
pressure at the fundus uteri was performed. The additional intro-
duction of haemostyptic material (Tabotamb) into the cervix did not
result in improved adhesive strength.
CONCLUSIONS
1.)The socalled f ibr in p lug did not in any case stem the f low of AF.
2.)The accessible region of the endocervix was always too wet to
al low good contact between FS and the cervical epi thel ium.
3.)The f ibr in p lug was either reabsorbed or expelled within 3 days
of application and this has to be repeatedly renewed.
4.)The f ib r in p lug was not adherent even with careful swabbing of
the accessible region of the endocervix and use of 90 mg/ml
protein.
REFERENCES
1.)Diaz-Zagoya, J. and F. Arias: "In vitro" sealing of ruptured
membranes with cryoprecipitate. Presented at the 27th Annual
Meeting of the Society for Gynecologic Investigation, March 19
-22, 1980, Denver, Colorado
2.)Genz, H.-J.: Die Behandlung des vorzeitigen Blasensprungs durch
Fibrinklebung. Med. Welt 30, No. 42, 1979, p. 1557
Dr. Carl Sylvius Kurz, Universitätsspital Zürich, Dept. für
Frauenheilkunde, frauenklinikstrasse 10, CH-8091 Zürich
